Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients

Feng‐Ming Tien; Hsin‐An Hou; Cheng‐Hong Tsai; Jih‐Luh Tang; Chien‐Yuan Chen; Yuan‐Yeh Kuo; Chi‐Cheng Li; Chien‐Ting Lin; Ming Yao; Shang‐Yi Huang; Bor‐Sheng Ko; Szu‐Chun Hsu; Shang‐Ju Wu; Woei Tsay; Mei‐Hsuan Tseng; Ming‐Chih Liu; Chia‐Wen Liu; Liang‐In Lin; Wen‐Chien Chou; Hwei‐Fang Tien

doi:10.1111/ejh.13073

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Hyperleukocytosis is an independent poor prognostic factor irrespective of cytogenetics and mutation status. Allo-HSCT in first CR seems to ameliorate the poor prognostic impact of HL.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tien et al. (2018) studied this question.

synapsesocial.com/papers/69dca9380de68e8319e5329b https://doi.org/10.1111/ejh.13073

View at Publisher

Ask AI

Bookmark

Share

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients

Ask about this paper

Abstract

Discussion

Cite This Study

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in de novo acute myeloid leukemia patients

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading